BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Rona Therapeutics and Keymed Biosciences Collaborate on siRNA Therapeutics for Glomerulonephritis

Under the term of the collaboration, Rona will use proprietary RAZOR™ platform to discover and identify siRNA lead compounds directed to a novel targ...

May 16, 2023 | News

Innovent's IBI351 gets NMPA breakthrough designation for advanced colorectal carcinoma

This BTD for IBI351 was based on the pooled analysis of two ongoing clinical trials (NCT05005234, NCT05497336), which include 54 CRC pa...

May 15, 2023 | News

Crystal Formulation Services' GMP facility passes remote US audit, marks global expansion milestone.

The audit was focused to confirm that the GMP manufacturing facility of CFS meets the US GMP regulations, and to ensure the compliance in manufacturing and...

May 15, 2023 | News

LaNova licenses novel cancer drug to AstraZeneca

LaNova Medicines Ltd. ("LaNova Medicines") announced it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305,...

May 15, 2023 | News

China's Guangzhou hosts Golden Age Single-Cell and Spatial Omics Conference

The conference brings together on site over 2,000 professionals from academia, research and development, investment and other fields interested to the conf...

May 09, 2023 | News

Biosion shares Anti-CD40 Agonistic Antibody discovery and development data at PEGS

BSI-038 is an anti-CD40 agonistic monoclonal antibody, discovered through Biosion's H³ antibody discovery platform. BSI-038 exhibits enhanced bin...

May 09, 2023 | News

Ascletis approved for Phase IIa clinical trial of ASC10 for RSV infection in China

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Do...

May 09, 2023 | News

Neuro3 Therapeutics obtains global rights for KCNQ2 activators from Lundbeck

The agreement focuses on activators of KCNQ2, an ion channel that has been clinically validated as a target for the treatment of epilepsy. Clinical findin...

May 09, 2023 | Opinion

Bliss Biopharmaceutical Collaborates with Eisai for Clinical Trial of BB-1701 with Strategic Option

This collaboration with Eisai is an important advancement in BlissBio's corporate development plan to further develop BB-1701 globally and help advance BB-...

May 08, 2023 | News

GenAssist's GEN6050 Base Editing Product Submits Pre-IND Application to FDA

Suzhou GenAssist Therapeutic Co.,Ltd recently announced its pre-IND application of their first base editing product, GEN6050 and the acceptance by the FDA....

May 08, 2023 | News

Duoning Biotech Celebrates Ground Breaking for Its Global Headquarters

The global headquarters of Duoning biotech is located in the heart of the Biotechnology Park, with a total construction area of over 40,000m2, includi...

May 08, 2023 | News

Hasten Biopharma Acquires Chinese Commercial Rights for Roche's Rocephin® Antibiotic.

Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has acquired the commercial rights in China for Rocephin®, a long-...

May 05, 2023 | News

Cambridge Infinitus Research Centre Launches AI-based ERnet Platform for Cellular Health Studies.

With an impact factor of 47.99, Nature Methods is the world's leading international publication for biochemical research methodology. Upon public...

May 05, 2023 | News

ABM Initiates Phase I Clinical Trial of MEK Inhibitor for Solid Tumor, Doses First Patient

MEK (mitogen-activated protein kinase kinase), a key kinase of the MAPK pathway, is frequently activated in various cancers, including those with RAS mutat...

May 05, 2023 | News

Stay Connected